cro.directory
← Compare landing

Cyagen Biosciences vs iXCells Biotechnologies

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryCyagen BiosciencesiXCells Biotechnologies
SummaryCyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical research, with specialized expertise in humanized mice, gene therapy vectors, and disease-specific models across oncology, neurology, and metabolic disorders.Offers iPSC reprogramming, CRISPR genome editing, directed differentiation, and in vitro bioassay and ASO screening services. Builds human iPSC-derived cellular models for preclinical drug discovery.
Services
  • Discovery Research
  • Preclinical In Vitro Studies
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • Specialized & Large-Animal Models
  • Translational Research
  • Discovery Research
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
Modalities
  • Biologics (Monoclonal Antibodies)
  • Oligonucleotide
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Oligonucleotide
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Rare Disease
  • Ophthalmology
  • Neurology
Phases
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
  • Discovery
  • Preclinical (General)
Sourcing models
  • Full-Service Outsourcing (FSO)
Data not yet provided.
Locations
  • Headquarters, Santa Clara, California, United States
Data not yet provided.
Certifications
  • AAALAC · Identifier: AAALAC-accredited facilities
Data not yet provided.

Find similar companies

Cyagen Biosciences alternatives · iXCells Biotechnologies alternatives

Markdown mirror: /compare/apac-cyagen/ixcells-biotechnology.md